Aktis Oncology, Inc. Common stock (AKTS)
Healthcare
Biotechnology
22.20 $
+0.7%
vs. previous close
Closing price · As of: 3. Aug 2026
Aktis Oncology, Inc. Common stock (AKTS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -64 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.0 | -1.1 | -5.5 | -14 | -18 | -21 | -45 | -18 | -30 | 15 | -64 | |
| 0.0 | 0.0 | 0.1 | 1.3 | 2.5 | 3.2 | 8.1 | 0.4 | 1.1 | 1.6 | 2.3 | |
| 0.2 | 0.4 | 3.9 | 5.5 | 7.2 | 6.7 | 10 | 0.7 | 1.5 | 2.3 | 5.1 | |
| 0.0 | 0.1 | 0.4 | 0.7 | -0.2 | 1.0 | -4.6 | -1.1 | 0.0 | 59 | -3.2 | |
| 0.1 | 0.0 | 1.7 | 7.0 | 4.9 | 10.0 | 28 | 2.3 | 3.8 | 2.9 | 9.6 | |
| -0.1 | 0.0 | -4.5 | -7.0 | -4.9 | -9.9 | -35 | -2.3 | -69 | -190 | 66 | |
| 4.9 | 2.6 | 16 | 26 | 38 | 45 | 72 | 120 | 33 | 183 | -1.2 | |
| 3.8 | 1.4 | 5.5 | 5.2 | 15 | 14 | -7.8 | 100 | -99 | 7.6 | 0.6 | |
| -1.1 | -1.1 | -7.2 | -21 | -23 | -31 | -73 | -20 | -34 | 12 | -74 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.